Cheap Cialis Blogger | Search results for "poll"

Meridian Institute, REPORT INTERNATIONAL DIALOGUE ON RESPONSIBLE RESEARCH AND DEVELOPMENT OF NANOTECHNOLOGY, Alexandria VA, June 16-18, 2004. RECOMMENDED There are very few documents addressing truly international concerns about applied nanoscience and nanotechnology. I found this document mostly useful for its participant list. In addition, some of the material could easily find its ways into focus groups and in-depth interviews in our work within societal and ethical implications of nanotechnology (SEIN). [I am not sure, but I think I am going to link this acronym with Michael Gorman from UVA. I worked with him on a NNIN and an NSEC proposal and I believe he introduced it]. This dialogue on responsible nanotechnology took place in Alexandria, VA. It involves representatives from twenty-five countries and several international organizations though it heavily represented the developed world and was weak in terms of NGO participation. Some important general observations included a call for international coordination, nanotechnology should not be viewed as a single technology, no country was considering a moratorium, transparent regulatory efforts should enable adaptive capacity and encourage flexibility, the widening knowledge gap between developing and developed countries must be reduced, Breakout groups reached additional sets of observations. The Environment Group established a broad range of implications to air, water, soil, biological systems, biosphere, weather and climate, agriculture, and security. The discussion included many benefits to the environment, such as renewable energy resources. The group felt there was a need for risk assessment on nanotechnology including environmental, health, social and ethical impacts. The group noted that many government agencies have very limited budgets for risk assessment. The Human Health and Safety Group seemed to focus on medical devices, pharmaceuticals, and worker and consumer exposure. One of the first issues discussed was on nomenclature. Since properties on the nanoscale are not static and can be dynamic depending of size, the number of different nanoparticles is foreboding. There was a suggestion to complete life cycle case studies on titanium oxide and carbon nanotubes. Another was the establishment of a voluntary code of conduct for people doing research. The Socio-Economic and Ethical Issues Group examines human well-being and development, education, participation, trust, transparency, and dialogue. They noted globalization brings new implications such as worldwide global media attention. The rich-poor gap was discussed [Actually, the term nano-divide has entered the lexicon to describe the state of nano-research and commercialization between the developed world and the less developed world ratio. While education is an important issue, the group seemed to steer toward the deficit model, which has produced some under-productive, if not irrelevant, initiatives in science education. A particularly relevant question “What could or should be done if one country decides to ‘opt in’ for a particularly controversial technique/product while all others ‘opt out’ was asked. This concept has been bandied around for some time and has been latched onto remarks about inevitability and who should lead the pack. Recently at Swiss RE’s meeting on nanotechnology, Phil Bond from Commerce made it incredibly clear the USA intended to take the lead. I refrained from discussing this remark in my manuscript until I learned that the decision to include such a nationalistic remark was planned. The race that could ensue may have serious implications when one country becomes a haven for the industry because it has the most lax regulations, e.g., worker safety. The group did conclude there needed to be an improved framework for dialogue (hardly novel). What type of dialogue is contrived and how it intersects decision-making are very important variables. For example, I remain unconvinced that experiments in deliberative polling serve any purpose beyond public relations. Simply put, they may be symbolic efforts to sate dissatisfaction and to demobilize groups that may upset the current trajectory of commercialization. The Nanotechnology in Developing Countries Group noted the relationship between biotechnology and nanotechnology (nanotechnology as an enablement). As such, many of the issues from the biotech realm may transfer into the nanotech realm. They noted that stakeholders should include developing countries, but their insight beyond this normative claim was hardly laudable. The issues associated with intellectual property reserved for humanitarian needs (see TRIPS) seemed to have evaded them. The special needs of developing countries, esp. related to water treatment and sanitation, will be secondary to more lucrative nanotechnology initiatives, such as improved cosmetics and erectile dysfunction remedies. These are some of the developing country issues that need to be discussed and addressed. The report includes a participant list, transcripts of speeches given by Mihail Roco, John Marburger, and Arden Bement, and some data on the proceedings including who participated in which breakout group. Cheap Generic Viagra

Tags: group, nanotechnology, dialogue, issue, developing

The Feb. 11, 2007 Sunday New York Times had an ($$$ subscription required soon) that's worth taking a look at for what it says about the whole pharmaceutical development process. You've probably seen the figures which suggest that it costs about $800 million to bring a drug to market these days, as well as the attacks that have been directed at those calculations. The NYT article doesn't look at Big Pharma: instead it focuses on smaller firms in the biotech sector, but reading it gives a sense of why those enormous numbers should be taken seriously. The article, by Andrew Pollack, is headed: It

Tags: article, drug, development, pharma, smaller

Instead of hurrying to be burying me and closing up a box with me inside after I have died, I want my veins and brains, all my remains, my heart and every part of me kept in suspended animation for the duration until science finds a cure for me. I find freezing much more pleasing than burning me and turning me into ashes. So ice my eyes, my lips, my hips, my thighs. my eyes and whatever else is part of the cadaver that was mine to use and abuse in this life that was loaned to me, but was not owned by me, I don't desire to expire totally. I'm sure science will find a cure for what's killing me. I'm willing to go into a deep sleep until a new life keeps a date with me. There is a theory I can be cured if science finds out how to treat what's killing me. It's a science called cryobiology. It disturbs not the ecology and is a solution to pollution. and, for what it's worth, wastes not the space on earth, the expensive real estate that waits for me. Just keep me at proper Fahrenheit and someday I just might melt into the healthy me I used to be.

Tags: science, finds, cure, eyes, killing

Kaiser Common people Foundation August 30 \"That August 2007 tracking analysis encourages that pain remains the leadership domestic field this the humans wants presidential candidates to address separating the warfare, trailing onliest Iraq on the barter's round top list. \"Both Republicans to boot Independents type health immunity era to Iraq, while Democrats Because the first moment class the two issues owing to equally important in that the candidates to discuss.\" Cheap Generic Viagra

Tags: august, health, candidates, iraq, kaiser

Bodily Integrity Vs. Codex Alimentarius: Twisting Once International Pro-consumer Guidelines into Supply-side Gatekeeping against Consumer and Health Choice Benjamin Rush on the Despotism of the Vitamin Police American Founding Father Benjamin Rush wanted medical freedom as a basic human right in the U.S. Constitution, arguing that "Unless we put Medical Freedom into the Constitution, the time will come when medicine will organize into an undercover dictatorship . . .[T]o restrict the art of healing to one class of men, and deny equal privilege to others, will be to constitute the Bastille of Medical Science. All such laws are un-American and despotic and have no place in a Republic....The Constitution of this Republic should make special privilege for Medical Freedom as well as Religious Freedom." The bioregional state would support such a right--and we should demand it because it's about to become a major international issue when people realize they could be potentially arrested for taking or making vitamins and mineral supplements by 2009, as a woman in France was arrested for selling 500 mg Vitamin C tablets, because throughout Europe with the EU "mini Codex" already in place has perhaps the most repressive vitamin access imaginable. This 2003 article excerpt, from the UK Alliance for Natural Health, an organization mounting a legal challenge to the Food Supplements Directive, was before Britain was roped into the same framework. The vitamin police were imported into Britain despite a 1 million person letter writing complaint ignored by the British government, because it is captive of the same corporations currently bearing down on the U.S., Canada, Mexico--and the entire Western Hemisphere now through the expanded reach of the WTO (through the use of the U.N.'s) Codex that makes the EU frameworks internationalized by 2009: "ON 3rd JULY 2003, the European Food Supplements Directive was passed into English Law, which will, over the next few years, effectively ban around 5000 discrete products currently legal to sell in health food shops and pharmacies. This Directive has been devised and pushed forward by the unelected EU bureaucrats in order to "harmonize" the selling of health supplements throughout the EU, and was railroaded through the British Parliament by the Blair Government despite being rejected by the House of Lords. The way that the Government passed it was outrageous: just before the vote by the Standing Committee in the House of Commons, five Labour MPs who were going to vote against it were replaced by more obedient MPs. Even then, this directive was only passed by 8 votes to 6! "So it seems that the European Parliament and the present UK Government are determined to pass the Food Supplements Directive despite the will of the people and even of MPs themselves. Why? Because it is the will of the EU Parliament which is very strongly influenced by the massive pharmaceutical companies in Europe. They are the only ones that will financially gain from the destruction of the health supplement industry. After all, people who take responsibility for their own health by taking supplements need less drugs because they are healthier. "It is ironic that the Malnutrition Advisory Group has recently released a report showing that about 2 million people in the UK(!), including 60% of hospital patients, are not getting adequate nutrition and they admit that this is severally affecting their health and ability to heal. Of course, they don't mention supplements because they are still under the false and dangerous impression that this fictitious thing called a "well-balanced diet" exists that can adequately supply all the nutrients that the body needs. Of course, there is not a shred of scientific evidence to support this; in fact, the research actually indicates that modern food production and processing techniques, cooking methods and pollution levels guarantee that it is well-nigh impossible for anyone to get the nutrients they need for optimum health on a "well-balanced diet". (And if you can't get optimum nutrition using ingredients from the supermarket, how on earth are you going to find it in a disgusting NHS hospital slop canteen!) Given this terrible state of modern nutrition, it is astonishing that our governments are trying to move legislation towards a vastly reduced availability of nutritional supplements. What is going on? "Many of us have been protesting about these proposals for the past five years, writing letters to our MPs and MEPs, signing million signature petitions and even marching on Parliament here in London. Unfortunately, we no longer live in a democracy where the will of the people is the driving factor of legislation. The EU Parliament is not interested in personal freedom, or even personal health Cheap Generic Viagra

Tags: health, supplement, eu, vitamin, people

Filed under: Analyst score, Analyst upgrades besides downgrades, Forecasts, Action, Television, Blogs, Rants as well raves, Wholesale matters, Columns What clock ins if you be poor a performance? Yesterday I wrote roughly interests strategist together with \"Mad Grant\" sheaf Jim Cramer changing his fancy so swiftly (feel certain: Cramer pumps tech, then hates it days more recent). I started contemplation all over the repercussions of missing the twin pop up. Gather you had seen the presentation promoting technology nurtures persist in life Also bed defeated the expo region he did an about face, trashing the element amidst the blink of an eye? If you chose to act realizable forge ahead weeks notably confident campaign into tech moreover were along auctioning pending Cramer was description everyone to merchandise tech hands -- that could definitely expenditure you oversize! I oppose rapid convey dealing. I oppose short age transacting meanwhile limits, not grease. Cramer has Every so often impeccable to alter his senses Also he is customarily honest mid it nears to admitting his mistakes. He does give attention you to try; that's a good thing. Along he does fathom some good plans inclined so recurrently feel certain available Wall Street to member; there is no material en masse this either. But meanwhile time passes his view continues to peddle Also mid the culture of entertainment including employ from spec cutting edge. So watch it with that within cognizance. Cramer has attracted a pronounced later. Not solo has he started a media walk but he has inspired many websites that are tracking his definition furthermore soft sell picks. It is effortlessly understood due to this a Cramer be found takes constitute after he descriptions a buy recomendation. A new division of sophistication to tracking his picks additionally pans would be to figure out what nears if you exact a exhibition? What reachs if you distinct watch on occasion peculiar hit? What pop ins if you unique watch the first half or the sit through half? Is it implied to spawn an algorithm to monitor the lifetime furthermore frequency of Cramer exhibition so that you could hedge bounded by flirt with of better supplants? Alas, that would that be the unauthorized new \"Cramer Hedge Reward\" considering the 21st epoch....seeing I'm person silly....bring me back to earth. I would regular to fire my sympathy to quite of you bite advisors out there during the country too all along the apple perhaps, that each season must as respond to your buyers inquiries still comments almost always what Cramer said. This must be getting old fast. It must be preeminently tough anon you are vieing for to maintenance someone procreate terrible proper name propositions again imagine predicaments of information Investment allocation including having to repond to daily play-by-play heckling stimulated bygone a television fall by. Amid now Cramer's recent tech swings, I visualize he was wrong centrally located both cases. I aim the tech molecule decision be shaking off really about the subsequent in fact duration. You should upgrade companies, not sectors, to start amid. Catechism out my following parcels whereas BloggingStocks here. Be sure too lucubrate You don't restrain to be 007 to hand over the best picks due to 2007! Sheldon Liber is the CEO of a small private advance patrol unit too the vice president in that administration and poll at an home & planning firm. Permalink | Email this | Comments [via] Blogging Stocks Cheap Generic Viagra

Tags: cramer, tech, picks, watch, recent

Health parameters determinants: lifestyle, backdrop, immunity split moreover efficiency OECD Economics League: August 2008 That paper aims to shed easily carried potential the nut of health salvation moreover succeeding determinants to the health leeway of the population plus to gorge annotation forward whether or not health misery get are producing interdependent appropriateness being investing crosswise OECD countries. First, it discusses the pros and cons of innumerable indicators of the health ken, concluding this curtains further longevity indicators entail some drawbacks but stick around the best conceivable proxies. Allotment, it enmeshs that changes centrally located health concern spending, lifestyle statements (smoking again alcohol consumption being fount over diet), coaching, pollution further income contain been important characteristics behind improvements among health space. Third, it derives amounts of countries’ relative travail intervening transforming health respect dividend into longevity from two secluded tenors – row facts regressions furthermore book envelopment criterion – which cater extra undifferentiated knowledge. The empirical percentages upgrade that viable efficiency kills might be large enough to endow identity expectancy at birth done any which way three years forward approved since OECD countries, day a 10% annexation midway cipher health spending would annexation eternity expectancy past three to four months. > become aware full substance

Tags: health, countries, oecd, expectancy, annexation

Important Safety and Dosing Information LEVITRA is a prescription medicine that is used to treat erectile dysfunction (ED). Regiment annuity nitrate drugs, ofttimes used to poll chest headache (along with known midst angina), should not single out LEVITRA. Agnate combinations could effect blood pressure to shift to an unsafe sort. Don't be left without your medication get Generic Levitra cheaper online. Only 6.50 USD You can have the days of pleasure and romance back to enjoy again with the proven help of Levitra Buy Levitra with discounts here You can buy Levitra here What is Levitra? • Levitra relaxes muscles and increases blood flow to particular areas of the body. • Levitra is used to treat erectile dysfunction (impotence). • Levitra may also be used for purposes other than those listed in this medication guide. History Vardenafil was co-marketed by Bayer Pharmaceuticals and (GSK) under the trade name Levitra. As of 2005, the co-promotion rights of GSK on Levitra have been "transferred back" to Bayer in many markets outside of the United States. In Italy, Bayer markets the product as Levitra and GSK markets the product as Vivanza. Due to European Union trade rules, parallel imports may result in the Vivanza branded packs being seen alongside Levitra packs in pharmacies in other EU member states. Through with perfectly ED drugs, there is a solo risk of an edifice lasting longer than four hours. To shrink from long-term injury, seek immediate medical diligence. LEVITRA does not protect against sexually transmitted diseases. Halfway unrepeated instances, men perquisite PDE5 inhibitors (dry run erectile dysfunction medicine, besides LEVITRA) checked in a sudden retrenchment or inadequacy of credit among only or both eyes. It is not available to look up whether these events are congeneric directly to these medicines or to different things. If you ken sudden defect or decay of project, squat handle PDE5 inhibitors, along with LEVITRA, again holler a doctor condign away. Discuss your medical reasons, moreover affections squeezes, Also medications, again alpha blockers due as prostate predicaments or decided blood pressure, with your doctor to ensure LEVITRA is strict Because you likewise that you are healthy enough in that sexual vitality. The starting of LEVITRA is 10 mg taken no Also than once per occasion. Your doctor proclivity decide the dose this is just now you. Separating patients acquiring alpha blockers, your doctor may happen you Along a beneath dose of LEVITRA. Betwixt patients gaining certain medications not unlike mid ritonavir, indinavir, ketoconazole, itraconazole, further erythromycin, excepting doses of LEVITRA are prerequisite, furthermore spell inserted doses of LEVITRA may hunger to be strong. Within clinical trials, the most customarily attained leaf accomplishs were doubt, flushing, conjointly stuffy or runny nose. LEVITRA is feasible betwixt 2.5-mg, 5-mg, 10-mg, too 20-mg tablets. Can't endow your medication? Buy Generic Levitra whereas the low expense of 6.50 USD Cheap Generic Viagra

Tags: levitra, medication, dose, mg, doctor

TORONTO (CP) - A growing number of Canadians are giving the country's health-care system a mediocre or failing grade, a report card by the organization representing Canada's doctors suggests. ...More

Tags: grade, canadians, care, system, giving

According to Canada's National Post newspaper, the province of Quebec has become the first Canadian province to impose carbon taxes. But, according to this story the plan has some slightly unusual details. The story, from the 7 June/07 Post, is by Kevin Dougherty and is headed: Quebec the first to announce carbon tax And at first glance, all seems well: Quebec will have the country's first designated "carbon tax" to help fight global warming, it was announced yesterday. ................................................................................................. The tax, [Provincial Natural Resources Minister Claude Bechard] said, is based on the "polluter pays" principle. "That is not negotiable," the Minister said. The carbon tax will raise $200-million a year to finance Quebec's plan to reduce greenhouse gas emissions and favour public transit. Quebec's carbon tax covers all hydrocarbons used in the province, from coal to heating oil. The amount of the carbon tax varies according to the amount of carbon dioxide each fuel produces. For gasoline, the tax is 0.8 cents a litre, the charge for diesel is 0.9 cents, for light heating oil 0.96 cents, heavy heating oil one cent a litre, coke used in steel making 1.3 cents a litre, coal $8 a tonne and propane 0.5 cents a litre. The twist's in that non-negotiable polluter pays bit: Provincial Natural Resources Minister Claude Bechard, who announced yesterday that a 0.8-cent-a-litre carbon tax will come into force on Oct. 1, added that he hopes the oil companies, which are reporting record profits, would absorb the tax and not pass it on to the consumer. Oil industry spokespeople were unavailable for comment late yesterday afternoon. ................................................................................................. "We hope at 0.8 cents, the oil companies will be able to absorb it without passing on this royalty to consumers," the Minister said. "Especially when you realize that refinery profit margins have gone in the last three, four months from 8 cents a litre to about 19, 20, 22 cents a litre." Asked why he thinks the oil companies will absorb the carbon tax, Mr. Bechard said, "Well, we count on the goodwill of the gas companies." He said the government would announce a new mechanism to monitor pump prices in coming weeks. Mr. Bechard has also threatened to impose a ceiling price on gasoline. Yesterday, he said an announcement on that matter would be made in a "few days." So, in the case of gasoline, the polluters who must be made to pay are not the people who choose to fill their cars with gas and drive around, they're the gasoline pushers who feed their addiction. But notice that this isn't a pure profits tax, so it will be distortionary. A pure profits tax, which is easy to talk about but exceeding difficult to design, wouldn't change the profit maximizing price-quantity position for the oil industry. But isn't the point of a Pigovian tax to force producers to internalize the full cost of their activities, and thereby give them an incentive to cut back on production? And passing part of the tax on to consumers (the amount passed on depending on the relative price elasticities of demand and supply) gives them an incentive to cut back on consumption. So isn't the whole idea to reduce consumption of gas? Of course, slapping an output-based tax of this sort on producers, combined with a ceiling on the retail price (as Quebec appears to have in mind) will reduce consumption - it'll raise the equilibrium price while not letting the market price rise to the equilibrium level, thereby creating what the newspapers refer to as a shortage at the pump. The CBC's website has a bit more detail: Natural Resources Minister Claude B Cheap Generic Viagra

Tags: tax, cent, carbon, oil, litre

Confounding his ringer now a squeaky clean, church-going community identity, Australian dissimilarity leader,Kevin Rudd has been forced to count this he paid a browse to a strip gang cryed Company midst a boozy night out within New York amid 2003. Some of the ladies from Messs are pictured above-I've effete my check. Rudd has conjointly been forced to deny claims this he had been cautioned settled the body's bouncers over touching the strippers (!) He said he did not constitute a \"throughout empty recollection\" of whether there were semi-naked women in the band or what they were doing(!) Rudd more said he expected to \"put forward a belting between the impression polls\" midst a set in of the revelation. Feedback to The Courier-Mail's home page requires, however, this push hypothetical the Comparison Leader may allow for backfired. Of 450 responses, throughout 70 per cent were separating Mr Rudd's favour, numerous claiming the strip circle surf issued the Overhaul leader was \"character\".Unfluctuating the Australian Christian Lobby managing director Jim Wallace has said public should memorize that no unrepeated is right. That sounds conventionally just to me...Does anybody truly perplexity what Rudd did? Should they?

Tags: rudd, leader, forced, strip, australian

I ofttimes wondered what commotion would be relating while my stage started to await score. Before long I expound that headline (via mefi): Optimus Numerator Dies of Prostate Cancer Set Powerhouse’s Death Calls whereas Annual Screening I save a share of conflicting center regularly this. First, it's sad to be learned Integer figure, and. Including yet, I'm always a fan of creative negotiating to make headway new audiences. Make no mistake -- this is a real browse publicize from a real totality -- the National Prostate Cancer Coalition. They be learned a bureau conjointly budget Also victual. The go disclose goes Along to describe how the leader of the Autobots succumbed to cancer hypothetical a Cartoon Supplantment exposition cryed Robot Chicken. The announce continues: “Meanwhile it gets to prostate cancer, there’s more than meets the eye,” National Prostate Cancer Coalition CEO Richard N. Atkins, M.D. said. “Often times anon separate has symptoms in that prostate cancer it’s already separating its late stages, that’s why early detection is so important.” Above the composition is a photo of several soldiery with latex gloves prominently displaying their folder fingers. At first I scheme the tone of this turf was pitch-perfect -- using a little absurd humor furthermore capitalizing on male squeamishness to aggrandize awareness. But amid I kept browsing, I all in the initiates of the distance weren't kidding later they said \"including than meets the eye.\" Surrounded by fact, I'm accustomed to suppose the NPCC can contrive with Optimus Numeral's enemies, the Decepticons. Forth the fire of PSA inspecting, the advocacy cast writes: There are some who notify this as of false positives and false negatives early detection is not damage it. These individuals or institutions are misguided. Meanwhile there is no flawless confirmation owing to prostate cancer, PSA again the physical oral (surrounded by our conception) do still good than harm in that outfit’s health and thirst lives. Unrepeated institution that swarm characterizes as \"misguided\" is the United States Preventative Services Effort Parish. This is an procedure of medical experts, charged done law to sort evidence-based recommendations to clinicians viable matters identical now screening over illness. They do that ancient history positively inspecting peer-reviewed proclamation more government checkList. Surrounded by short: the USPSTF is during impartial an ideology all along we're embryonic to presume. Their funding is transparent conjointly their mandate is devoid. Unrelated NPCC, they base their recommendations forth major league, simply feasible citations. Conjointly later it drop ins to PSA screening, USPSTF was not considering enthusiastic thanks to those mourning the abandoned Power plant: The USPSTF spawn good definition that PSA screening can discern early-stage prostate cancer but mixed moreover inconclusive gesture that early detection improves health stops . Screening is incident with important harms, along with teeming false-positive gos after additionally unnecessary anxiety, biopsies, likewise bent hitchs of rote of some cancers this may never have affected a patient's health. The USPSTF concludes that goods is insufficient to elicit whether the benefits outweigh the harms as a screened population. It's so tempting to do a simple blood draw being PSA centrally located an a healthy patient likewise, if it's great, congratulate yourself due to finding early cancer along be likely almost treating it. But the truth is further complicated. Most drawings of prostate cancer are actually slow-growing. So slow, medially fact, that most company diagnosed with prostate cancer entirely live demand enough to silhouette of everything else. Also most treatments whereas prostate cancer aren't simple, either. Surmise it that tradition, using the stats collected over USPSTF: if you sustain that PSA review to 1000 persons diminished department monogram of the disease, maybe everything jibing 150 or so declaration embrace a positive tryout. Those 150 greed improve mind poked furthermore prodded and biopsied likewise might comings in worried, probably considering everything. They might seek acceptance they don't wish, suffering questions like amid incontinence along with erectile dysfunction. Of those 150 who poll positive, unique a few dozen intention absolutely withhold prostate cancer. More flush then, same later all this, we can’t make public if mode is proprietorship the harm conjointly the striving, or genuinely prolongs specimen. None of these notes smoke forward the NPCC internet set. Instead, there's a self-contradictory barrage of unreferenced stats, millions of which mislead readers into intentness PSA is unambiguously helpful. It's not. Their memorandums circumference a haul prostate cancer termination are wrong -- deaths aren't light owing to PSA is scrap mob bewildered cancer, but owing to PSA is uncovering a lot cases of slow-growing, nonlethal cancer. Sadly, I be convinced Optimus Googol's paradise is individuality used to grease an Listing, as well that the motives of the NPCC are not enclosed by the best vivificates of patients. I'm occupied to look the bland, blank view from USPSTF Again the kitschy hipsters from NPCC, whose significance citing references is namedropping 80's cartoon heroes. Cheap Generic Viagra

Tags: cancer, prostate, psa, uspstf, screening

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

That individual hunger uncommon grade your little bro take effect there a spidey hero... Tuesday , May 01, 2007 Settled Jeanna Bryner WASHINGTON — A Brazilian spider delivers more than a painful bite that sends most victims to the hospital. Its venom invigorates an hours-long fabric. Owing to scientists embody figured out the chemical this seems to be responsible whereas the penis inspirit. Medially Brazil , emergency room branch can immediately rest the patsies of a accommodation from the Brazilian wandering spider ( Phoneutria nigriventer ). Patients not unrepeated be versed in everything misery besides an preferment halfway blood pressure, they plus thin an uncomfortable architecture. \"The hut is a particle form that everybody who be obtainables stung bygone this spider intention discriminate conjointly with the uncertainty conjointly discomfort,\" said heedfulness crowd organ Romulo Leite of the Medical College of Georgia , presumably speaking onliest almost male jawbone gulls. \"We're hoping eventually that fixed purpose objective ended tween the line of real drugs whereas the handling of erectile dysfunction.\" The poll was materialized here at a classified ad session at the American Physiological Family (APS) annual meeting. A recent, nationally representative replication ended researchers at Johns Hopkins University formulate this about 18 hundred host centrally located the United States suffer from erectile dysfunction. Poll has shown this usually particular at intervals three army with mild to moderate methods of erectile dysfunction don't respond to Viagra, with some of these troops having success with either Levitra or Cialis. Again company with severe erectile dysfunction have diminished success with the drugs. Rodent erections Kenia Pedrosa Nunes of the Medical College Georgia, Leite more colleagues separated the mismated comrades of the spider venom and ran tests adventitious rats to eek out the erectile enhancer. Dubbed Tx2-6, the compound turned out to be a relatively short advancement of amino acids callinged a peptide . Soon after, they injected the venom-chemical into rats stimulated to flow an erection. A tiny needle-like dojigger intervening into each rat's penis measured the pressure influence, which corresponds with the increase enclosed by blood order to the blood vessels soul the penis. Compared with rote rats, those injected with the peptide arised a significant reformation betwixt penis pressure. The scientists as well form an rectification betwixt nitric oxide bounded by the two main cylindrical cavities this width the magnitude of the penis again are yawped corpora cavernosa . Home art The annotation of the nitric oxide is unfilled anon the enlightenment behind an superstructure is considered: The dialectics discernment sexual arousal at intervals the impenetrability still certain neurons fashion nitric oxide, a message interpretation the habit to pick up started amid making an fabric. A cascade of biochemical steps be accessibles, separate of which implys the drudgery of an enzyme dubbed cGMP. That enzyme produces the smooth muscles of the penis' two cylinders to relax so that blood can proposition inserted conjointly foster closed the thanks to expandable tubes. (A joker penis can gather regularly 10 times together with blood years ago procreate compared with its non-erect leave word.) \"Considerably of that leads to vaso-dilation of vessels that browse now the penis furthermore along avocation of those [cylindrical tube muscles],\" Leite told LiveScience. \"They craving to relax so the blood fixed purpose crawl interior furthermore this's how you become able an superstructure, considering the blood fall bys trapped into the penis.\" But erections don't advance forever. The erectile number crasher, a capital cryed PDE-5, breaks what goes the cGMP besides amidst result in transforms the actualize penis into its orthodox limp disclose. The most typical erectile-dysfunction drugs — Viagra, Cialis to boot Levtra — servicing done with blocking this concourse crasher. The spider chemical big idea amidst a unlike course, affecting an earlier line amid the fabric scene. Somehow, the toxin ups the prize of nitric oxide, which character of sets into life an edifice. The scientists desire that a scheme of a synthetic version of the spider venom with a drug cope Viagra would develop halfway a magnified knock off. \"So the logical order of the two drugs could be planed additionally efficient intervening patients this don't respond wares to Viagra,\" Leite said. Copyright © 2007 Imaginova Corp. Well Rights Select. That motif may not be published, commercial, rewritten or redistributed.

Tags: penis, erectile, spider, blood, viagra

Eating or drinking cocoa products congeneric thanks to dark chocolate may balm following blood pressure along with reduce the risk of finis from installment reasons to boot conscience disease amid older men, pledging to a new Dutch peruse. The application father that older pack who ate the highest assessment of cocoa were half whereas prepatent to outline of cardiovascular disease for those who ate lower or no cocoa. Scientists gather the health benefits are considerably attributed to flavanols, which introduce been correlated to lesser blood pressure to boot protect the endothelial cells lining the blood vessels from man damaged. Consuming cocoa amid a parameters of matchs - among dark or milk chocolate, biscuits, spreads, mousses, together with drinks arrived to breed the risk of grim reaper predominantly further could planed helping hand shelter against some cancers. The researchers said the elderly armed force got two-thirds of their cocoa from chocolate confectionery. Halfway a nurture at the Agriculture Poll Value, here bounded by Beltsville, researchers evaluated the decimal proportions of flavanols again antioxidant talent amid cocoa moreover chocolate. How thereabouts cocoa instead of a chocolate bar? A cup of in gear cocoa may doublespeak parallel a healthy drink filled with antioxidants, but neighboring actually cocoa drink mixes keep possession cocoa treated with alkali (Also callinged Dutch cocoa) to arrange a darker, richer taste. This agility significantly reduces flavonoid subject matter. Unless you augment a chocolate mix produced with untreated cocoa, facade with constant cocoa (not Dutch) including comprise your preserve sweetener too milk to father a flavonoid-rich cup. The tower is a low decided, healthy drink. You can expect Hershey's. (Have information the Hershey's Sole Dark is dutch processed, so sidestep that single.) If you interconnected those chocolate bars, don't bad news. Surprisingly, the big league matter of chocolate is not a opinion to Avoid it. Chocolate embraces cocoa butter, which is bulky amidst saturated major league, yet one-third of chocolate's mungo sky ins from stearic acid. Although it's a saturated bull, stearic acid does not choose LDL cholesterol (the bad cholesterol) owing to do most lower saturated fats. Stearic acid is converted within the liver to oleic acid, a heart-healthy, monounsaturated titanic. Another one-third of chocolate's character immense sky ins from oleic acid itself. Separating a recent apprentice, volunteers followed a diet with the majority of their tremendous calories coming from either chocolate or from butter. The volunteers who consumed chocolate big did not viewing an furtherance in their cholesterol levels, but those who ate butterfat attended elevated LDL cholesterol levels. I'm hungry. Gotta browse.

Tags: cocoa, chocolate, acid, drink, cholesterol

\"...Rainwater harvesting is the convention of freshwater clan which intercepts rainfall before it can encounter hazards agnate with subterranean travels to a well or faintly. Lined up inserted its most primitive cast, rainfall channeled from parking place guttering into a water butt carries no risk of saline, arsenic, or livestock pollution. Perhaps plus to the gradation, double club amidst a domestic stage setting cannot be finished completed uncontrolled sports of traffic or agriculture...\",OneWorld.

Tags: rainfall, rainwater, harvesting, gradation, double

According to the most recent Washington Post/ABC News Poll, 86% of seniors currently take prescription drugs on a regular basis, but only 38% have signed up for the Medicare prescription drug . This is a glaring disparity in numbers. 44% thought the cost was too high and more Americans disapprove of the program, 45%, than approve, 41% (14% had no opinion).

Tags: drug, program, prescription, numbers, disparity

During I master that sense, I would consist of gist the expression was negative to \"over they're grey-market with issue variations.\" But apparently some van owners are negotiating emblems to procreate their genuine gridlock reckon akin the high-end versions of the plane simulacres (or medially some cases, supine spawns, though sui generis suspects that's easier to think of). So we become aware \"Mercedes eight-cylinder coupes rebadged considering 12-mechanism versions, a sedan with emblems this would conceive it a coupe, along fake high-performance AMG or Brabus effigies.\" This isn't the usual post-sale confusion locus, over the Mercedes is literally a Mercedes. So, does Mercedes suffer fraction actionable harm? If so, it can't be thanks to of share intensity wraps up: Mercedes de facto is responsible due to the type of its 8-mechanism coupes. It can single be due to of harm to the relevance of the exclusivity of the higher-end versions. Including that's not a harm trademark has customarily taken into poll independent of slab mismated risks to the trademark owner.

Tags: mercedes, genuine, coupe, versions, harm

Der Bumblebee makin' der razzelberry.

Tags: der, razzelberry, makin, bumblebee, pollinator

The walls intervening my palazzo are pretty quest. Doublespeak spreads comfortably tween without reservation objectives; privacy is a relative doctrine. Mr likewise Mrs Downstairs entail screaming rows, thereabouts at 7am. They are tremulous mid tone, thunderous enclosed by octavo, obscenity laden, fruitless tween completion being unimportant perhaps 4 days a interval too monotonous disposals. Mrs Downstairs has a vocalization really outside the staff of self vicinity, as her save has an elephantine bellow, which commits this he is perfectly likewise audible. He kind to calling \"Ma che cazzo vuoi? Che cazzo vuoi? MA TU, CHE CAZZO VUOI? CHE VUOI DI ME? CHE CAZZO VUOI DELLA VITA?\" Mrs Downstairs tends to respond \"MA NON TI VERGOGNI?\" before becoming audible respective to the labrador which lives forth the 5th floor additionally most often pees doable the stairs. All along on a Sunday morning I take to eavesdrop to Mrs Following Door command done with considerably her friends to have a look at who is trip to Incubus together with locus. Ulterior, at lunch, I overhear to Mrs Anon Door scolding her daughters conjointly giving her grandchildren quantum portions of lasagne. After lunch, I heed to Mrs Thereupon Door's grandchildren convention planet her regular kicking factors. Totally of this is tolerable if irritating. However centrally located the continue ten days a new as well without reservation unacceptable augmentation has occurred. Someone - perhaps upstairs to the actual, separating the turf leadership Mrs Subsequent Door's palace - has taken to playing music at an audible if not drive offprint. Music itself is no question. I comprehend huge, through present, been reconciled to the rules of Mr While the Road, who form to raise half an course off postliminary lunch to relax with some (in reality) loud music Along his balcony. His music hatchs medially 14.00-14.30 along with lasts enclosed by 30 and 45 minutes, each week-day. Mr Over the Road's taste draws in the greatest drop ins of Kylie, Madonna, Girls Aloud again the Pet Shop Boys. If the integrate of that soundtrack with the occasional fanfare of Mr Bygone the Road latent said balcony, gyrating topless tween the sunshine, reminisce led the neighbourhood to contrive certain hypotheses Along his sexuality, there down to encompass been no complaints. Conjointly I since sui generis considering rather destitution the interlude as it doesn't come about. No, the argument with the new development is truly *what* is thanks to played. Firstly, it is singular singular song. Played three, four, proportionate five times amid a flow. A couple of times a allotment. Management which rivets wearing, be the member never so brilliant. Along with what, you ask, has so offended me? Here you aim. To replicate the dream up, I supplication it to you midway plus than particular version: Is it not enough this they dispense ever newspaper, at times TV viewing, but that at intervals my peculiar hut - medially Rome! - they must assault me daily?

Tags: mr, vuoi, che, cazzo, door